marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
AIM ImmunoTech Financial Ratios 2011-2024 | AIM
Annual Financial Ratios AIM ImmunoTech
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -2.3 | -5.5 | -0.4 | -1.0 | -1.8 | -1.9 | -1.4 | -2.4 | -4.5 | -2.4 | -7.1 |
P/S |
143.2 | 327.1 | 484.6 | 26.3 | 26.5 | 33.5 | 156.5 | 159.8 | 210.3 | 490.8 | 198.6 | 395.4 |
EPS |
-0.4 | -0.4 | -0.5 | -2.6 | -9.8 | -0.3 | -0.3 | -0.8 | -1.1 | -0.1 | -0.1 | -0.1 |
EV (Enterprise Value) |
-6.86 M | 12.1 M | 40.5 M | 9.52 M | 18.1 M | 18.7 M | 15.4 M | 21.6 M | 43.7 M | 75.4 M | 53.1 M | 66.1 M |
EBITDA per Share |
-0.41 | -0.38 | 0.0476 | -3.2 | -10.6 | -16 | -25.2 | -34.6 | -50.4 | -51.4 | -73.6 | -53.3 |
EV/EBITDA |
1.8 | 42.6 | -0.5 | -1.2 | -1.4 | -1.0 | -1.2 | -2.2 | -4.5 | -2.0 | -4.6 | |
PEG |
0.0 | 0.01 | -0.06 | -0.01 | -0.04 | -0.12 | -0.04 | -0.04 | -0.24 | -0.27 | 0.03 | -0.24 |
P/B |
0.5 | 0.8 | 1.3 | 0.3 | 1.9 | 1.7 | 0.9 | 1.0 | 1.7 | 2.5 | 0.9 | 1.7 |
P/CF |
-1.3 | -3.2 | -7.6 | -0.4 | -0.9 | -1.8 | -1.8 | -1.3 | -2.8 | -4.1 | -2.2 | -5.2 |
ROE % |
-50.55 | -33.63 | -23.49 | -73.86 | -189.66 | -94.90 | -48.41 | -74.76 | -69.79 | -55.38 | -38.82 | -23.75 |
ROA % |
-48.03 | -33.15 | -22296.54 | -47.15 | -70.88 | -58.13 | -39.75 | -66.79 | -59.27 | -50.91 | -30.08 | -20.72 |
ROCE % |
-51.79 | -33.12 | 1868.25 | -65.17 | -134.41 | -99.27 | -83.98 | -81.73 | -76.38 | -58.52 | -45.15 | -37.18 |
Current Ratio |
- | - | 36.6 | 9.3 | 0.7 | 1.3 | 2.9 | 4.3 | 3.7 | 7.3 | 3.5 | 6.3 |
DSO |
- | 46.0 | 0.1 | 2137.9 | 1088.0 | 20.0 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | 302.9 | - | - | 83.1 | 313.9 |
DPO |
- | - | 0.2 | 192.9 | 280.8 | 228.6 | 292.2 | 277.1 | 607.2 | 375.9 | 395.8 | 588.3 |
Operating Cycle |
- | 46.0 | 0.1 | 2137.9 | 1088.0 | 20.0 | - | 302.9 | - | - | 83.1 | 313.9 |
Cash Conversion Cycle |
- | 46.0 | -0.1 | 1944.9 | 807.3 | -208.6 | -292.2 | 25.8 | -607.2 | -375.9 | -312.7 | -274.4 |
All numbers in USD currency
Quarterly Financial Ratios AIM ImmunoTech
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | -0.03 | -0.12 | - | -0.16 | -0.1 | -0.08 | - | -0.13 | -0.1 | -0.08 | - | -0.08 | -0.12 | -0.08 | - | -0.08 | -0.11 | -0.22 | - | -1.13 | -1.07 | -2.91 | - | -2.87 | -2.38 | -0.07 | - | -0.04 | -0.08 | -0.11 | - | -0.13 | -0.06 | -0.1 | - | -0.18 | -0.02 | -0.02 | - | -0.02 | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 | -0.05 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
EBITDA per Share |
- | - | -0.12 | - | - | - | -0.09 | - | -0.14 | -0.1 | -0.07 | - | - | -0.07 | -0.08 | - | - | -0.1 | -0.18 | - | -1.02 | -1.5 | -2.36 | - | -2.22 | -2.74 | -0.06 | - | -0.06 | -0.08 | -0.12 | - | -0.11 | -0.11 | -0.16 | - | -0.16 | -0.02 | -0.02 | - | -0.02 | -0.03 | -0.03 | - | -0.02 | -0.03 | -0.03 | - | -0.03 | -0.02 | -0.03 | - | -0.02 | -0.02 | -0.03 |
ROE % |
-312.26 | -219.79 | -205.99 | -61.33 | -76.29 | -56.66 | -50.32 | -32.07 | -38.23 | -29.44 | -28.47 | -20.18 | -25.57 | -24.80 | -21.33 | -17.10 | -39.94 | -57.39 | -67.67 | -64.69 | -124.18 | -160.83 | -191.73 | -158.60 | -172.99 | -127.88 | -106.41 | -72.00 | -90.47 | -94.55 | -77.76 | -40.84 | -59.51 | -59.71 | -75.08 | -59.36 | -75.30 | -72.57 | -68.61 | -51.10 | -62.01 | -63.60 | -58.40 | -55.38 | -56.69 | -53.89 | -45.99 | -38.82 | -34.82 | -27.30 | -26.63 | -23.75 | -7.22 | -6.04 | -2.28 |
ROA % |
-102.90 | -103.72 | -106.64 | -42.66 | -56.45 | -42.19 | -37.12 | -30.38 | -36.45 | -28.72 | -27.99 | -19.70 | -24.82 | -23.88 | -20.29 | -16.23 | -30.81 | -40.27 | -45.13 | -41.29 | -63.52 | -71.18 | -78.55 | -59.27 | -68.08 | -54.66 | -52.66 | -44.11 | -59.27 | -65.62 | -57.09 | -33.53 | -50.21 | -51.72 | -66.07 | -53.03 | -67.30 | -64.90 | -60.49 | -44.14 | -54.16 | -56.01 | -52.61 | -50.91 | -50.35 | -45.65 | -37.41 | -30.08 | -27.77 | -22.66 | -22.73 | -20.72 | -6.30 | -5.27 | -1.99 |
ROCE % |
-369.60 | -251.53 | -209.12 | -66.49 | -81.76 | -60.94 | -52.45 | -30.81 | -37.14 | -28.20 | -24.25 | -17.28 | -22.76 | -21.90 | -21.67 | -16.35 | -41.18 | -60.54 | -80.07 | -72.48 | -131.20 | -165.08 | -202.47 | -170.76 | -201.23 | -172.99 | -141.98 | -99.08 | -119.90 | -110.24 | -97.03 | -62.71 | -82.26 | -81.00 | -86.90 | -67.78 | -84.20 | -81.06 | -77.34 | -57.20 | -72.42 | -71.22 | -67.04 | -46.95 | -58.06 | -53.94 | -45.91 | -27.62 | -36.99 | -35.25 | -35.68 | -27.38 | -9.37 | -8.56 | -9.46 |
Current Ratio |
1.3 | 1.6 | 1.4 | 2.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.6 | 6.9 | 7.0 | 9.8 | 12.4 | 12.4 | 12.4 | 12.4 | 4.4 | 4.4 | 4.4 | 4.4 | 7.8 | 7.8 | 7.8 | 7.8 |
DSO |
- | - | - | - | 80.3 | - | - | - | - | - | - | - | 77.4 | 123.0 | 110.8 | - | 86.2 | 77.6 | 79.1 | - | 65.8 | 138.4 | - | - | 564.3 | 649.8 | 211.0 | - | 24.3 | 10.3 | 13.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 313.6 | 218.3 | 404.0 | - | 620.6 | 645.9 | 473.5 | - | 460.2 | 182.6 | 818.9 | - | 199.2 | 946.3 | 625.4 | - | 706.9 | 751.9 | - |
Operating Cycle |
- | - | - | - | 80.3 | - | - | - | - | - | - | - | 77.4 | 123.0 | 110.8 | - | 86.2 | 77.6 | 79.1 | - | 65.8 | 138.4 | - | - | 564.3 | 649.8 | 211.0 | - | 24.3 | 10.3 | 13.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 80.3 | - | - | - | - | - | - | - | 77.4 | 123.0 | 110.8 | - | 86.2 | 77.6 | 79.1 | - | 65.8 | 138.4 | - | - | 564.3 | 649.8 | 211.0 | - | 24.3 | 10.3 | 13.0 | - | - | - | - | - | -313.6 | -218.3 | -404.0 | - | -620.6 | -645.9 | -473.5 | - | -460.2 | -182.6 | -818.9 | - | -199.2 | -946.3 | -625.4 | - | -706.9 | -751.9 | - |
All numbers in USD currency